Opolentisima, Joel A.

HRN: 28 51 56  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/20/2026
CO-AMOXICLAV 625MG (TAB)
02/20/2026
02/26/2026
PO
625mg
TID
Cap LR
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: Compliant To Guidelines